Clinical trials
Expanded access trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 15 |
| Approved for marketing | 12 |
| Available | 4 |
| Temporarily not available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| Bayer | 2 |
| Eisai Inc. | 2 |
| Nuvalent Inc. | 2 |
| Tibotec Pharmaceuticals, Ireland | 2 |
| Bial R&D Investments, S.A. | 1 |
| BioMarin Pharmaceutical | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| HIV Infections | 2 |
| Recurrence | 2 |
| Angioedema | 1 |
| Angioedemas, Hereditary | 1 |
| COVID-19 | 1 |
| Carcinoma, Medullary | 1 |
| Carcinoma, Renal Cell | 1 |
| Central Nervous System Diseases | 1 |
Trials
Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.